Walleye Capital’s Aprea Therapeutics APRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-80,000
| Closed | -$376K | – | 2629 |
|
|
2023
Q4 | $376K | Sell |
80,000
-2,356
| -3% | -$11.1K | ﹤0.01% | 1262 |
|
|
2023
Q3 | $345K | Sell |
82,356
-11,271
| -12% | -$47.2K | ﹤0.01% | 1280 |
|
|
2023
Q2 | $295K | Buy |
93,627
+364
| +0.4% | +$1.15K | ﹤0.01% | 1190 |
|
|
2023
Q1 | $415K | Buy |
+93,263
| New | +$415K | 0.01% | 1059 |
|
|
2021
Q3 | – | Sell |
-4,947
| Closed | -$483 | – | 1552 |
|
|
2021
Q2 | $483 | Sell |
4,947
-977
| -16% | -$95 | 0.02% | 741 |
|
|
2021
Q1 | $604 | Buy |
5,924
+884
| +18% | +$90 | 0.04% | 475 |
|
|
2020
Q4 | $496 | Buy |
+5,040
| New | +$496 | 0.03% | 470 |
|